{"id":"https://openalex.org/W3025892139","doi":"https://doi.org/10.26355/eurrev_201809_15834","title":"Fasudil alleviates hepatic fibrosis in type 1 diabetic rats: involvement of the inflammation and RhoA/ROCK pathway.","display_name":"Fasudil alleviates hepatic fibrosis in type 1 diabetic rats: involvement of the inflammation and RhoA/ROCK pathway.","alternate_titles":[],"publication_year":2018,"publication_date":"2018-09-01","ids":{"openalex":"https://openalex.org/W3025892139","doi":"https://doi.org/10.26355/eurrev_201809_15834","mag":"3025892139","pmid":"https://pubmed.ncbi.nlm.nih.gov/30229844"},"language":"en","primary_location":{"id":"pmid:30229844","doi":"https://doi.org/10.26355/eurrev_201809_15834","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30229844","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European review for medical and pharmacological sciences","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W3025892139"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029668589","display_name":"Yang Xie","orcid":"https://orcid.org/0000-0002-5666-3618","observed_orcids":["https://orcid.org/0000-0002-5666-3618"]},"institutions":[{"id":"https://openalex.org/I111381250","display_name":"Hebei Medical University","ror":"https://ror.org/04eymdx19","country_code":"CN","type":"education","lineage":["https://openalex.org/I111381250"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Y Xie","raw_affiliation_strings":["Department of Pharmacology, Hebei Medical University, Shijiazhuang, China. chuli0614@126.com","Department of Pharmacology, Hebei Medical University, Shijiazhuang, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Hebei Medical University, Shijiazhuang, China. chuli0614@126.com","institution_ids":["https://openalex.org/I111381250"]},{"raw_affiliation_string":"Department of Pharmacology, Hebei Medical University, Shijiazhuang, China;","institution_ids":["https://openalex.org/I111381250"]}]},{"author_position":"middle","author":{"id":null,"display_name":"T Song","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T Song","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108712397","display_name":"Huo M","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Huo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075677041","display_name":"Y Zhang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y Zhang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090229741","display_name":"YY Zhang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y-Y Zhang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100296736","display_name":"Ma Zh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Z-H Ma","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026532114","display_name":"N Wang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N Wang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106184123","display_name":"Zhang Jp","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J-P Zhang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"L Chu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L Chu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.9481,"has_fulltext":false,"cited_by_count":28,"citation_normalized_percentile":{"value":0.85490154,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"22","issue":"17","first_page":"5665","last_page":"5677"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10966","display_name":"Liver physiology and pathology","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10966","display_name":"Liver physiology and pathology","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.008999999612569809,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fasudil","display_name":"fasudil","score":1.0},{"id":"https://openalex.org/keywords/liver-fibrosis","display_name":"liver fibrosis","score":0.9900000095367432},{"id":"https://openalex.org/keywords/type-1-diabetes","display_name":"type 1 diabetes","score":0.9950000047683716},{"id":"https://openalex.org/keywords/rhoa-rock-signaling-pathway","display_name":"RhoA/ROCK signaling","score":0.9340000152587891},{"id":"https://openalex.org/keywords/rock1","display_name":"ROCK1","score":0.8009999990463257},{"id":"https://openalex.org/keywords/nf-kappab","display_name":"NF-\u03baB","score":0.8759999871253967},{"id":"https://openalex.org/keywords/liver-inflammation","display_name":"liver inflammation","score":0.8140000104904175},{"id":"https://openalex.org/keywords/tgf-beta1","display_name":"TGF-\u03b21","score":0.9670000076293945},{"id":"https://openalex.org/keywords/extracellular-matrix-accumulation","display_name":"extracellular matrix accumulation","score":0.9169999957084656},{"id":"https://openalex.org/keywords/captopril","display_name":"captopril","score":0.9629999995231628},{"id":"https://openalex.org/keywords/streptozotocin-induced-diabetes","display_name":"streptozotocin-induced diabetes","score":0.8690000176429749},{"id":"https://openalex.org/keywords/hepatoprotective-effect","display_name":"hepatoprotection","score":0.5979999899864197}],"concepts":[{"id":"https://openalex.org/C2776048814","wikidata":"https://www.wikidata.org/wiki/Q5437132","display_name":"Fasudil","level":4,"score":0.9804906845092773},{"id":"https://openalex.org/C2780559512","wikidata":"https://www.wikidata.org/wiki/Q605709","display_name":"Fibrosis","level":2,"score":0.6107575297355652},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.594883143901825},{"id":"https://openalex.org/C2778609687","wikidata":"https://www.wikidata.org/wiki/Q18390224","display_name":"Rho kinase inhibitor","level":4,"score":0.5900527238845825},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5282273292541504},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5274434685707092},{"id":"https://openalex.org/C2779280383","wikidata":"https://www.wikidata.org/wiki/Q257331","display_name":"Streptozotocin","level":3,"score":0.5248389840126038},{"id":"https://openalex.org/C201800478","wikidata":"https://www.wikidata.org/wiki/Q24721770","display_name":"Rho-associated protein kinase","level":3,"score":0.5157647132873535},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4694965183734894},{"id":"https://openalex.org/C2993667909","wikidata":"https://www.wikidata.org/wiki/Q147778","display_name":"Hepatic fibrosis","level":3,"score":0.4461725652217865},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.4251294732093811},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3448227643966675},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.3183046877384186},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.1174832284450531},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07583928108215332}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003921","descriptor_name":"Diabetes Mellitus, Experimental","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003921","descriptor_name":"Diabetes Mellitus, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003921","descriptor_name":"Diabetes Mellitus, Experimental","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D003921","descriptor_name":"Diabetes Mellitus, Experimental","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008103","descriptor_name":"Liver Cirrhosis","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D008103","descriptor_name":"Liver Cirrhosis","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D008103","descriptor_name":"Liver Cirrhosis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008103","descriptor_name":"Liver Cirrhosis","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019307","descriptor_name":"1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D019307","descriptor_name":"1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D020741","descriptor_name":"rho GTP-Binding Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D054460","descriptor_name":"rho-Associated Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D054460","descriptor_name":"rho-Associated Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:30229844","doi":"https://doi.org/10.26355/eurrev_201809_15834","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30229844","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European review for medical and pharmacological sciences","raw_type":"Journal Article"},{"id":"mag:3025892139","doi":"https://doi.org/10.26355/eurrev_201809_15834","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30229844","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W29660629","https://openalex.org/W4294127571","https://openalex.org/W1967741960","https://openalex.org/W2612304705","https://openalex.org/W2020799712","https://openalex.org/W3013304292","https://openalex.org/W2140141583","https://openalex.org/W2340740808","https://openalex.org/W2039832565","https://openalex.org/W998007265"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Rho-associated":[1],"kinases":[2],"(ROCKs)":[3],"are":[4],"recognized":[5],"to":[6,19,38,74,138,186],"be":[7],"involved":[8,142],"in":[9,32,143,213,246],"many":[10],"pathophysiological":[11],"processes":[12],"caused":[13],"by":[14,159],"hyperglycemia.":[15],"We":[16],"performed":[17],"experiments":[18],"evaluate":[20],"the":[21,25,40,76,140,160,163,174,179,182,187,195,198,207,214,231],"effects":[22],"of":[23,114,122,162,181,189,197,209,216,233],"fasudil,":[24],"Rho/ROCK":[26],"inhibitor,":[27],"on":[28],"preventing":[29],"hepatic":[30,150,244],"fibrosis":[31,151,200,245],"type":[33,126],"1":[34],"diabetic":[35,59,217],"rats":[36,48],"and":[37,67,85,94,100,103,134,156,191,211,228],"elucidate":[39],"underlying":[41],"mechanisms.":[42],"MATERIALS":[43],"AND":[44],"METHODS:":[45],"Sprague-Dawley":[46],"(SD)":[47],"were":[49,97,107,136],"randomly":[50],"divided":[51],"into":[52],"five":[53],"groups:":[54],"normal":[55],"control":[56],"(NC),":[57],"untreated":[58],"(DM),":[60],"low-dose":[61],"fasudil-treated":[62,65],"(L-Fas),":[63],"high-dose":[64],"(H-Fas)":[66],"captopril-treated":[68],"(Cap)":[69],"groups.":[70],"Streptozotocin":[71],"was":[72],"injected":[73],"establish":[75],"diabetes":[77],"model.":[78],"Alanine":[79],"aminotransferase":[80,83],"(ALT),":[81],"aspartate":[82],"(AST)":[84],"inflammatory":[86],"factors":[87],"such":[88],"as":[89],"tumor":[90],"necrosis":[91],"factor-\u03b1":[92],"(TNF-\u03b1)":[93],"interleukin-6":[95],"(IL-6),":[96],"analyzed.":[98],"Hematoxylin":[99],"eosin":[101],"(HE)":[102],"Masson's":[104],"trichrome":[105],"staining":[106],"used":[108],"for":[109,242],"histological":[110],"observations.":[111],"The":[112,146],"expression":[113],"transforming":[115],"growth":[116],"factor-\u03b2":[117],"(TGF-\u03b21),":[118],"metalloproteinase-9":[119],"(MMP-9)/tissue":[120],"inhibitor":[121],"metalloproteinase-1":[123],"(TIMP-1),":[124],"collagen":[125],"I\u03b1":[127],"(Coll":[128],"\u03b11),":[129],"nuclear":[130],"factor-kappa":[131],"B":[132],"(NF-\u03baB)":[133],"ROCK-1":[135,210],"measured":[137],"investigate":[139],"mechanisms":[141],"fibrosis.":[144],"RESULTS:":[145],"DM":[147],"group":[148],"exhibited":[149],"with":[152,167,201],"remarkable":[153],"liver":[154,199],"damage":[155],"inflammation":[157,175],"reaction":[158,176],"activation":[161,208],"NF-\u03baB":[164,212],"pathway.":[165],"Treatment":[166],"fasudil":[168,204,224],"or":[169],"captopril":[170],"suppressed":[171],"not":[172],"only":[173],"but":[177],"also":[178],"accumulation":[180,232],"extracellular":[183,234],"matrix":[184],"due":[185],"downregulation":[188],"TGF-\u03b21":[190],"MMP-9/TIMP-1,":[192],"which":[193],"induces":[194],"amelioration":[196],"diabetes.":[202,247],"Furthermore,":[203],"significantly":[205],"attenuated":[206],"livers":[215],"rats.":[218],"CONCLUSIONS:":[219],"These":[220],"results":[221],"suggest":[222],"that":[223],"exert":[225],"anti-inflammation":[226],"actions":[227],"markedly":[229],"decrease":[230],"matrix.":[235],"Fasudil":[236],"is":[237],"a":[238],"good":[239],"candidate":[240],"agent":[241],"treating":[243]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3025892139","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2020-05-21T00:00:00"}
